Click the button below to submit content to the weekly newsletter.
NIDA Diversity Scholars Networks (NDSN)
Deadline: Friday, January 7, 2022
The NDSN is a competitive, rigorous, and comprehensive program aimed at enhancing the funding success of underrepresented early-stage investigators conducting substance abuse and addiction research.
Georgia Department of Public Health Daily Status Report
View information on COVID-19 in the State of Georgia including confirmed cases, ICU admissions, hospitalizations, and deaths. Charts present the number of newly confirmed COVID-19 cases over time and are meant to aid understanding of whether the outbreak is growing, leveling off, or declining to help guide COVID-19 response. COVID-19 Vaccine Dashboard
Interactive dashboard with information about vaccines administered, vaccination by county, and race and ethnicity data.
Need help navigating the DOM Research Administration Service (RAS) Unit?
The team has issued a one-page document to assist you in working your way through the grant submission process.
If interested in submitting a proposal, please reach out to the DOM RAS Pre-Award Inbox at least 45 days in advance with the following information; due date, sponsor, and project duration. Please provide the RFA/PA or link from the sponsor.
Funding & Award Opportunities
The Center for AIDS Research at Emory University (Emory CFAR)
Deadlines: Friday, October 1 (LOI); Monday, November 1 (Full application)
The Emory CFAR will fund a variable number of one-year pilot awards up to $40K for research projects that aim to advance HIV prevention, treatment, care, and/or cure strategies. There are two opportunities available: 1) a CFAR-03 to help faculty generate preliminary data to strengthen the competitiveness of subsequent NIH applications that align with NIH/OAR high-priority areas of HIV research and 2) a CFAR-K to provide funds that augment or extend HIV-relevant NIH K research funding. Learn more Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
Deadline: Thursday, February 3, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to support pilot and feasibility trials of interventions designed to improve technology adoption in individuals from underrepresented backgrounds with type 1 diabetes mellitus (T1D). Learn more Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
Deadline: Thursday, February 3, 2022
The supplement is intended to allow candidates to expand their research experience to help them transition beyond their clinical training to the next stage of their research careers as physician-scientists. Learn more Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
Deadlines: 30 days prior (LOI); Thursday, March 17, 2022
The purpose of this FOA is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. Learn more Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) (U01)
Deadline: Friday, June 17, 2022
The APS Consortium will seek to understand the heterogeneity and underlying mechanisms of critical illness syndromes and recovery, specifically in adults with ARDS, pneumonia, and sepsis, as well as the relationship and biological overlap between these syndromes. Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes in the Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)
Deadlines: Monday, July 11 and Thursday, August 11, 2022
The purpose of this initiative is to support projects that further develop or exploit advances using in situ or in vivo imaging or related technologies to investigate HIV/SIV infection, latent reservoirs, the pathogenic consequences of HIV/SIV infection, or the effects of substance use, substance use disorders (SUDs), or HIV or SUD therapies on these processes. Learn more Development and Preliminary Testing of Health-related Behavioral Interventions
Deadline: Various, closes Monday, September 26, 2022
This FOA encourages translational behavioral intervention research, integrated with basic behavioral and social science, aimed at creating, refining, and testing novel interventions focused on the initiation, cessation, or maintenance of behaviors associated with improved health or disease mitigation. Learn more Notice of Special Interest: Alcohol-induced Tissue-specific and Organ System Diseases (R01/R21/R03)
Deadline: Rolling, May 8, 2024
The purpose of this NOSI is to inform potential applicants of the special interest in research project applications studying the harmful effects of alcohol on the body’s tissues, organs, and systems in diverse populations across the lifespan. Learn more NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 – Independent Clinical Trial Not Allowed)
Deadlines: April 25, 2022; April 25, 2023 (LOI); May 25, 2022, 2023 (Full application)
The purpose of this FOA is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. Learn more
COVID-19 Funding Opportunities
Visit the DOM intranet for archived COVID funding opportunities in a searchable database compiled from FOAs in the weekly What's Up in DOM Research newsletter.
Emory credentials required to view.
Chandan Devireddy (Cardiology) received funding from Ablative Solutions, Inc. for a project entitled, “The TARGET BP I Trial: A pivotal, multicenter, blinded, sham procedure-controlled trial of renal denervation by the Peregrine System kKt, in subjects with hypertension.” Monica Farley (Infectious Diseases) received funding from CDC Foundation for a project entitled, “Establishment of Group B Streptococcal immunologic endpoints reasonably likely to predict clinical benefit against invasive disease among young infants: a multi-state case-control study.” Vasilis
Babaliaros (Cardiology) received funding from Edwards Lifesciences LLC for a project entitled, “COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV Post-Approval Study (COMPASSION).”
Have you or a colleague recently received an award or grant funding?
Recent Notable Publications
Ram Subramanian (Digestive Diseases)
Hu C, Anjur V, Saboo K, Reddy KR, O'Leary J, Tandon P, et al. Low predictability of readmissions and death using machine learning in cirrhosis. Am J Gastroenterol. 2021 Feb 1;116(2):336-346. Read more Andre Holder (Pulmonary)
Condeni MS, Basting AT, Costello PG, DePriest A, Eriksson EA, Evans H, et al. Major publications in the critical care pharmacotherapy literature: 2019. J Crit Care. 2021 Apr;62:197-205. Read more Modele Ogunniyi (Cardiology)
Cho L, Vest AR, O'Donoghue ML, Ogunniyi MO, Sarma AA, Denby KJ, Lau ES, Poole JE, Lindley KJ, Mehran R; Cardiovascular disease in women committee leadership council. Increasing participation of women in cardiovascular trials: JACC Council Perspectives. J Am Coll Cardiol. 2021 Aug 17;78(7):737-751. Read more Ann Vandenberg, Laura Plantinga (Geriatrics), Janice Lea, Tahsin Masud (Renal Medicine), and Christopher O'Donnell (Hospital Medicine)
Vandenberg AE, Jaar BG, James KP, Lea J, O'Donnell C, Masud T, Mutell R, Plantinga LC. Making sense of DialysisConnect: a qualitative analysis of stakeholder viewpoints on a web-based information exchange platform to improve care transitions between dialysis clinics and hospitals. BMC Med Inform Decis Mak. 2021 Feb 9;21(1):47. Read more Michael Koval (Pulmonary)
Smith P, Jeffers LA, Koval M. Measurement of lung vessel and epithelial permeability in vivo with Evans blue. Methods Mol Biol. 2021 Jan 19. Read more
Have you or a colleague recently published an article?
Emory SOM FAALI Lecture Series: New digital tools to aid collaboration
Wednesday, September 8 ǀ noon – 1 p.m. ǀ Zoom
Different programs such as Teams, SharePoint, OneDrive, and Zoom can be overwhelming. Join this session to learn how faculty can use these programs to effectively collaborate in real life situations and to learn tips to make these programs more useful in both education and research settings. 2021 DOM Honors and Awards Celebration
Tuesday, September 14 ǀ 5:30 – 7:30 p.m. ǀ Zoom
Please join the Department of Medicine for a virtual celebration of faculty and staff honors and awards. This annual event will honor our faculty and staff award nominees, clinical distinctions, and senior
promotions.
Space is limited. Please RSVP by Monday, August 30th. Register Export controls in research and academic settings: New regulations on the export of information and technology to foreign countries
Wednesday, September 22 ǀ 4 – 5 p.m.
Do you know what happens if you violate export controls? The ordinary meaning of the term export, where a physical item is transferred to a foreign location is well understood. Export regulations, however, apply equally to intangible property such as information and technology. This webinar will explain how to stay out of trouble with the new export regulations. The Learning Objectives for this workshop include:
1. Provide an overview of export control regulations
2. Highlight types of activities impacted by the regulations
3. Provide a summary of research and academic activities that are not subject to export control regulations
Register
Do you have an upcoming event or educational opportunity?
Bryan Wells
Associate Professor - Cardiology What is your professional background?
I am a clinical cardiology and vascular medicine physician at Emory University Hospital Midtown. In addition to inpatient and outpatient clinical work, I read echocardiography, nuclear stress tests, and vascular imaging. I also function as a small group advisor for the School of Medicine. I teach learners at every level of training including students, residents, and fellows. When I am not performing clinical or teaching duties, I enjoy participating in clinical research. In what division do you work, and who is your mentor?
I work in the Division of Cardiology. I have many mentors including Larry Sperling, Bob Taylor, and Angel Leon. Briefly describe your research. Why is it important?
My research primarily focuses on rare non-atherosclerotic vascular diseases including fibromuscular dysplasia (FMD) and spontaneous coronary artery dissection (SCAD). Emory is a center for both of these national registries, and I am the site PI for both. From the FMD and iSCAD registries, we have been able to answer many important clinical questions pertaining to these disorders. I am also involved with multiple clinical trials involving treatment for the hypercoagulable effects of COVID-19. What do you like most about Emory?
I love that Emory is accepting and inclusive of individuals from diverse backgrounds – all over the world. I also like that our colleagues are supportive and collaborative. What is your favorite movie or TV show?
Recently, my three children and I have been watching most of the Marvel movies. My favorite TV show is any psychological thriller on Netflix. What do you like to do in your spare time?
I spend most of my free time training and racing in triathlons. My family enjoys spending time at the mountains and the lake. What is a fun fact about you?
I used to play the drums. During medical school, my friends and I played shows and recorded a studio album.
"What's Up" is brought to you by Emory University's Department of Medicine Office of Research.
|